Skip to main content

Antibody Based Diagnostic and Therapeutic Approach for Alzheimer's Disease

Abstract Alzheimer's disease (AD) is the most common form of dementia leading to cognitive dysfunction and memory loss as well as emotional and behavioral disorders. It is the 6th leading cause of death in United States, and the only one among top 10 death causes that cannot be prevented, cured or slowed. An estimated 5.4 million Americans live with AD, and this number is expected to triple by year 2050 as the baby boomers age. The cost of care for AD in the US is about $200 billion each year. Unfortunately, in addition to the lack of an effective treatment or AD, there is also a lack of an effective diagnosis, particularly an early diagnosis which would enable treatment to begin before significant neuronal damage has occurred.

Increasing evid... (more)
Created Date 2014
Contributor Tian, Huilai (Author) / Sierks, Michael R (Advisor) / Dai, Lenore (Committee member) / Tillery, Stephen H (Committee member) / Nielsen, David R (Committee member) / Stabenfeldt, Sarah (Committee member) / Arizona State University (Publisher)
Subject Biomedical engineering / Chemical engineering / Alzheimer's Disease / atomic force microscopy (AFM) / biomarker / phage display biopanning / Single Chain Variable Fragments (scFvs) / tau oligomers
Type Doctoral Dissertation
Extent 155 pages
Language English
Reuse Permissions All Rights Reserved
Note Doctoral Dissertation Chemical Engineering 2014
Collaborating Institutions Graduate College / ASU Library
Additional Formats MODS / OAI Dublin Core / RIS

  Full Text
3.3 MB application/pdf
Download Count: 2984

Description Dissertation/Thesis